# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001213900-24-006971
Filing Date
2024-01-26
Accepted
2024-01-26 16:05:57
Documents
4
Period of Report
2024-03-12

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEFINITIVE PROXY STATEMENT | ea192072-def14a_citiuspharma.htm | DEF 14A | 346066
2 | GRAPHIC | image_001.jpg | GRAPHIC | 24106
3 | GRAPHIC | image_002.jpg | GRAPHIC | 509276
4 | GRAPHIC | image_003.jpg | GRAPHIC | 369318
| Complete submission text file | 0001213900-24-006971.txt |  | 1590757

Mailing Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016
Business Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016 (908) 967-6676
Citius Pharmaceuticals, Inc. (Filer) CIK: 0001506251 (see all company filings)

EIN.: 273425913 | State of Incorp.: NV | Fiscal Year End: 0930
Type: DEF 14A | Act: 34 | File No.: 001-38174 | Film No.: 24567757
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)